The ASCO Nominating Committee has selected 11 distinguished members as candidates for open leadership positions within the Society. Voting Members are urged to vote in the election beginning November 2, 2022. Voting will close on December 6, 2022.

President-Elect (4-year term)

Robin Zon, MD, FACP, FASCO
Michiana Hematology Oncology

Board of Directors – Designated Community Oncologist (one seat, 4-year term)

Debra A. Patt, MD, MBA, PhD, FASCO
Texas Oncology

David R. Spigel, MD, FASCO
Sarah Cannon Research Institute / Tennessee Oncology

Board of Directors – Designated Surgical Oncologist (one seat, 4-year term)

Matthew H. G. Katz, MD, CMQ, FACS, FASCO
The University of Texas MD Anderson Cancer Center

Kathleen Moore, MD, MS
Stephenson Cancer Center at the University of Oklahoma

Board of Directors – Undesignated Member (one seat, 4-year term)

Blase N. Polite, MD, MPP, FASCO
University of Chicago Medical Center

Jennifer S. Temel, MD
Massachusetts General Hospital

Nominating Committee – Undesignated Member (two seats, each a 3-year term)

Laura Williams Goff, MD, MSCI
Vanderbilt University Medical Center 

Sumanta K. Pal, MD, FASCO
City of Hope

Tiffany A. Traina, MD
Memorial Sloan Kettering Cancer Center

Neha Vapiwala, MD, FACR, FASTRO
University of Pennsylvania Abramson Cancer Center

Election results will be announced in mid-December 2022, and newly elected leaders will begin their terms in office in June 2023. Please contact ASCO Election staff with any questions.